FDMT — 4D MOLECULAR THERAPEUTICS INC

Ownership history in US BANCORP \DE\  ·  14 quarters on record

This page tracks every 13F SEC filing in which US BANCORP \DE\ reported a position in 4D MOLECULAR THERAPEUTICS INC (FDMT). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 57 -190 -76.9% 0.00% $495 $8.69
2024 Q4 REDUCED 247 -755 -75.3% 0.00% $1K $5.57
2024 Q3 REDUCED 1,002 -102 -9.2% 0.00% $11K $10.81
2024 Q2 REDUCED 1,104 -756 -40.6% 0.00% $23K $20.99
10 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    FDMT price (monthly, adj. close)

Other funds also holding FDMT

As of 2025 Q4 — sorted by position size

Novo Holdings A/S 3Y 7Y 2.13% BVF INC/IL 3Y 7Y 1.17% RA CAPITAL MANAGEMENT, L.P. 3Y 7Y 0.43% Parkman Healthcare Partners LLC 3Y 0.36% Privium Fund Management B.V. 3Y 0.29% Rangeley Capital, LLC 0.24% ARMISTICE CAPITAL, LLC 3Y 7Y 0.17% Evergreen Quality Fund GP, Ltd. 0.14% Burkehill Global Management, LP 0.14% SILVERARC CAPITAL MANAGEMENT, LLC 3Y 0.1%
← Back to US BANCORP \DE\ Holdings